Viking Therapeutics (VKTX) P/E (2015 - 2026)
Viking Therapeutics (VKTX) P/E from Apr 29, 2015 to Jul 20, 2026. The TTM Viking Therapeutics (VKTX) P/E is -8.81. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Viking Therapeutics (VKTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -8.81 | -20.62% |
| 2025 | -11.09 | -72.70% |
| 2024 | -40.63 | +99.49% |
| 2023 | -20.37 | +73.13% |
| 2022 | -11.77 | +80.42% |
| 2021 | -6.52 | -37.22% |
| 2020 | -10.39 | -53.79% |
| 2019 | -22.48 | +1.47% |
| 2018 | -22.15 | +333.10% |
| 2017 | -5.12 | +449.92% |
| 2016 | -0.93 | -24.54% |
| 2015 | -1.23 | N/A |
Comparison Viking Therapeutics (VKTX) P/E with competitors
Viking Therapeutics (VKTX) P/E is -8.81.